You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 12, 2024

CLINICAL TRIALS PROFILE FOR VIVACAINE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for VIVACAINE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00915473 ↗ Greater Occipital Nerve Block for Migraine Prophylaxis Completed National Center for Advancing Translational Science (NCATS) Phase 4 2009-06-01 Migraine is a common neurological condition that can be disabling, particularly if chronic. Greater occipital nerve (GON) block has been utilized for decades for the treatment of migraine in the absence of a single randomized, placebo-controlled trial documenting its effectiveness. Hypothesis: Greater occipital nerve block reduces the frequency of days with moderate or severe headache in patients with episodic or chronic migraine.
NCT00915473 ↗ Greater Occipital Nerve Block for Migraine Prophylaxis Completed Mayo Clinic Phase 4 2009-06-01 Migraine is a common neurological condition that can be disabling, particularly if chronic. Greater occipital nerve (GON) block has been utilized for decades for the treatment of migraine in the absence of a single randomized, placebo-controlled trial documenting its effectiveness. Hypothesis: Greater occipital nerve block reduces the frequency of days with moderate or severe headache in patients with episodic or chronic migraine.
NCT01906944 ↗ Ultrasound Guided Transversus Abdominis Plane (TAP) vs. Trigger Point Injection (TPI) for Abdominal Wall Pain Completed Mayo Clinic Phase 2 2012-01-01 Patients with chronic abdominal pain- with a component of abdominal wall pain- are often treated with trigger point injections. This study will help to determine if a block within the transversus abdominis plane (TAP) will provide superior analgesic benefit to a trigger point injection as therapy for these patients.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for VIVACAINE

Condition Name

Condition Name for VIVACAINE
Intervention Trials
Migraine Headache 1
Abdominal Pain 1
Irreversible Pulpitis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for VIVACAINE
Intervention Trials
Pulpitis 1
Abdominal Pain 1
Migraine Disorders 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for VIVACAINE

Trials by Country

Trials by Country for VIVACAINE
Location Trials
United States 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for VIVACAINE
Location Trials
Minnesota 1
Arizona 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for VIVACAINE

Clinical Trial Phase

Clinical Trial Phase for VIVACAINE
Clinical Trial Phase Trials
Phase 4 1
Phase 2/Phase 3 1
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for VIVACAINE
Clinical Trial Phase Trials
Completed 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for VIVACAINE

Sponsor Name

Sponsor Name for VIVACAINE
Sponsor Trials
Mayo Clinic 2
Cairo University 1
National Center for Advancing Translational Science (NCATS) 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for VIVACAINE
Sponsor Trials
Other 3
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.